Travere Therapeutics, Inc. <TVTX.O>: Guggenheim raises target price to $75 from $65
TVTX•Related News
Merck & Co Inc <MRK.N>: JP Morgan raises target price to $150 from $140
MRK•
Henry Schein, Inc. <HSIC.O>: Leerink Partners Raises Target Price to $96 From $88
HSIC•
Global Markets-Stocks up in Asia as tech mood shifts, oil slides
SPY•
Kloeckner sets profit goal, sees slight shipment decline in 2026
WS•
Cincinnati Financial Corporation <CINF.O>: KBW Cuts Target Price to $190 From $201
CINF•